Finance

Lists
4582:TYO
Symbio Pharmaceuticals Ltd
56,00 JPY
+1,82%
(+1,00) 1D
30 სექ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4582...
Open
55 JPY
High
57 JPY
Low
55 JPY
Mkt. cap
4,49 მლრდ.
Avg. vol.
824,10 ათ.
Volume
511,50 ათ.
52-wk high
229 JPY
52-wk low
53 JPY
EPS
-98 JPY
Shares outstanding
82,40 მლნ.
No. of employees
91
Open
55 JPY
High
57 JPY
Low
55 JPY
Mkt. cap
4,49 მლრდ.
Avg. vol.
824,10 ათ.
Volume
511,50 ათ.
52-wk high
229 JPY
52-wk low
53 JPY
EPS
-98 JPY
Shares outstanding
82,40 მლნ.
No. of employees
91
About Symbio Pharmaceuticals Ltd
CEO-
Employees91
Founded25 მარ. 2005
Headquartersმინატო, ტოკიო, იაპონია
SectorPharmaceutical industry
Websitesymbiopharma.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
324,17 მლნ.
336,19 მლნ.
233,46 მლნ.
235,54 მლნ.
Cost of goods sold
122,29 მლნ.
84,64 მლნ.
60,63 მლნ.
71,37 მლნ.
Cost of revenue
122,29 მლნ.
84,64 მლნ.
60,63 მლნ.
71,37 მლნ.
Research and development expenses
868,70 მლნ.
846,40 მლნ.
1,99 მლრდ.
-1,99 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
518,54 მლნ.
506,73 მლნ.
522,11 მლნ.
3,45 მლრდ.
Operating expense
1,39 მლრდ.
1,35 მლრდ.
2,51 მლრდ.
1,46 მლრდ.
Total operating expenses
1,51 მლრდ.
1,44 მლრდ.
2,57 მლრდ.
1,53 მლრდ.
Operating income
-1,19 მლრდ.
-1,10 მლრდ.
-2,34 მლრდ.
-1,29 მლრდ.
Other non operating income
-1,57 მლნ.
14,49 მლნ.
-6,26 მლნ.
85,26 მლნ.
EBT including unusual items
-1,20 მლრდ.
-1,19 მლრდ.
-2,39 მლრდ.
-1,21 მლრდ.
EBT excluding unusual items
-1,20 მლრდ.
-1,09 მლრდ.
-2,39 მლრდ.
-1,22 მლრდ.
Income tax expense
-3,66 მლნ.
18,88 მლნ.
13,97 მლნ.
4,03 მლნ.
Effective tax rate
0,30%
-1,58%
-0,58%
-0,33%
Other operating expenses
-
-
-
-
Net income
-1,20 მლრდ.
-1,21 მლრდ.
-2,40 მლრდ.
-1,22 მლრდ.
Net profit margin
-369,09%
-360,02%
-1 028,60%
-516,94%
Earnings per share
-
-
-
-
Interest and investment income
1,73 მლნ.
653,00 ათ.
2,25 მლნ.
-
Interest expense
-29,04 მლნ.
-11,12 მლნ.
-16,63 მლნ.
-16,62 მლნ.
Net interest expenses
-27,31 მლნ.
-10,47 მლნ.
-14,38 მლნ.
-16,62 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები